Kenneth P. Vogel @kenvogel
By 2015, the prescription painkiller Opana was being widely abused & linked to clusters of disease. Its maker, Endo, had scaled back promotion of the drug. Then McKinsey secretly helped devise a plan to sell more of it, using more sales representatives. https://t.co/89wk8iQePr — PolitiTweet.org